JPRN-UMIN000019103已完成未知
Evaluation of efficacy and safety of the Qing Dai in patients with ulcerative colitis: A muticenter, double-blind, randomized controlled trial. - A muticenter, double-blind, randomized controlled trial of the Qing Dai.
The Jikei University Kashiwa Hospital0 个研究点目标入组 68 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients with... 1. newly start or dose-up of 5-ASA within two weeks. 2. newly start or dose-up of steroids within two weeks. 3. newly start or dose-up of immunomodulators, such as azathioprine/6-methyl mercaptopurine within three months. 4. with biological products, such as Infliximab, and Adalimumab. 5. any herbal medicine containing the Qing Dai. 6. a possibility of pregnancy, during pregnancy, or lactating. 7. any mental illness that interfere to participate this trial. 8. active bacterial/fungal infections 9. history of myocardial infarction or unstable angina within three months. 10. uncontrollable hypertension 11. respiratery disease requiring a sustained oxigen administration.
研究者
相似试验
尚未招募
1 期
Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenzainfluenzaITMCTR2000002885onghua Hospital Shanghai University of Traditional Chinese Medicine
已完成
不适用
Investigation of clinical efficacy of Qing-Dai for patients with crohn's disease who have the loss of responsiveness for anti-TNF agentss diseaseCrohn's diseaseJPRN-UMIN000019249Division of Gastroenterology and Hepatology, School of Medicine, Keio University10
招募中
1 期
The Efficacy and Safety of Huoxuo Qianyang Qutan Dection in the Treatment of Hypertension: a Randomized, Double-blind, Placebo-controlled TrialhypertensionITMCTR2000003526Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
招募中
1 期
Efficacy and safety evaluation of modified Yin Qiao San in the treatment of COVID-19 --A randomized, double-blind, placebo-controlled clinical trialITMCTR2200006829The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Traditional Chinese Medicine)
招募中
4 期
???????????????????ITMCTR2200005917Gansu Province second People's Hospital